President:

Roland Baron - Boston, USA and Paris, France
Email:roland_baron@hsdm.harvard.edu

Roland Baron DDS PhD
Roland Baron is currently Professor and Chair at the Department of Oral Medicine Infection and Immunity, Harvard  School of Dental Medicine.  Dr Baron is an exceptional and accomplished scientist and leader. Trained as a dentist in Paris, he earned post graduate certificates in Oral Biology and Periodontology as well as a PhD in Odontology. He is internationally known for his groundbreaking advances in bone biology. His research is the basis for the development of novel therapies to prevent bone loss such as that in arthritis and osteoporosis.

Dr. Baron, who has over 250 publications, is the Editor-in-Chief and Founder of the Journal, Bone and Associate Editor of the Journal of Cellular Physiology. He has won numerous professional honors, and in 2005 was the recipient of the D. Harold Copp Award in Basic Research from the International Bone and Mineral Society. Dr. Baron is a member of the many Scientific Advisory Committees. Most recently, he served as President and Chief Scientific Officer at the Prostrakan Group and he has also held other significant leadership positions in pharmaceutical companies.

Dr. Baron’s laboratory is focused on signal transduction and the ways in which it controls cell differentiation and function.

Past-President:

Richard Eastell, Sheffield, UK
Email: r.eastell@sheffield.ac.uk

Richard Eastell BSc (Hons), MBChB, MD (Edin), FRCP (London, Edin), FRCPI (Hon), FRCPath, FMedSci
Professor Eastell is Professor of Bone Metabolism at the University of Sheffield and Director of the NIHR Biomedical Research Unit in Bone Diseases at the Sheffield Teaching Hospitals Trust. He qualified in medicine from Edinburgh in 1977.  He trained in endocrinology at the Mayo Clinic under Dr B L Riggs for 5 years. He leads a research group on the pathogenesis, diagosis and treatment of osteoporosis; of particular note is the contribution to the clinical utility of biochemical markers of bone turnover and the development of treatments for osteoporosis. The publications of the Sheffield group put them in the top 4 internationally in osteoporosis (ISI Thompson). His work has been recognised by the award of the Corrigan Medal (Royal College of Physicians of Ireland, 1998), Kohn Foundation Award ( National Osteoporosis Society, 2004) and Society for Endocrinology Medal (2004).

Secretary:

Tim Arnett, London, UK
Email: t.arnett@ucl.ac.uk

Tim Arnett BSc PhD
BSc (East Anglia, 1974);  PhD (London, 1984).   Postdoc positions at Columbia University & University College London (1984-6).   Lecturer, Senior Lecturer & Reader at UCL (1986-2007).   Currently Professor of Mineralised Tissue Biology in Dept of Cell & Developmental Biology at UCL.   Research interests centred on the control of osteoclast and osteoblast function by fundamental regulators (eg, extracellular pH, oxygen, nucleotides).    Member of EU FP7 consortium (‘ATPbone’).   Member of editorial boards of several journals, including Endocrinology & CTI.   

Treasurer:

Bente Langdahl, Aarhus, Denmark
Email: bente.langdahl@aarhus.rm.dk

Bente Langdahl MD
Education/Positions: MD, University of Aarhus (1988). PhD and DMSc, University of Aarhus (1995 and 2004). Specialist in Endocrinology (2002). Associate professor, Clinical Research Institute, University of Aarhus (2001-). Head of Osteoporosis Department, Aarhus University Hospital (2003-).
Awards: Research prize, The Danish Society of Internal Medicine (1995). Young Investigator Award, European Calcified Tissue Society (1997). Research prize, The Bone Decade (2002).
Editorial Duties: Editorial Board: Calcif Tissue Int. Reviewer: Osteoporos. Int, Bone, J Bone Min Res, Eur J Endo, Eur J Rheum and J Clin Endocr Metab.
Member of Societies: ECTS, ASBMR and IBMS.

Additional Board Members:

Miep Helfrich, Aberdeen, UK
Email: m.helfrich@abdn.ac.uk

Miep Helfrich MSc PhD
Miep Helfrich    graduated with a MSc in Biology from the University of Wageningen, The Netherlands in 1983. She continued her scientific training as a PhD student at the Department of Cell Biology and Histology at the University of Leiden, where she worked on osteoclast development in osteopetrosis. After gaining her PhD in 1988 she did her first postdoc with Mike Horton at the Imperial Cancer Research Fund (now CRUK) in London. She was appointed as post-doctoral research fellow in the Department of Medicine and Therapeutics in Aberdeen in 1992 and was awarded an ARC post doctoral research fellowship in 1997. This was extended in 2001 for 3 years. She was promoted to senior research fellow in 2001 and appointed as senior lecturer in October 2004. Since the opening of IMS phase II she has been active in establishing a core facility for histology and electron microscopy. She is currently director of this facility.

Maria Luisa Bianchi, Milan, Italy
Email: ml.bianchi@auxologico.it

Maria Luisa Bianchi MD
Born in Milan, Italy, Dr Bianchi gained her MD degree cum laude at the University of Milano, Italy, in 1979; specialization cum laude in Medical Nephrology in 1982.

Between 1982 and 1996 she worked as an Assistant Nephrologist in the First Medical Clinic of the University of Milano at the Ospedale Maggiore Policlinico. Since 1996 she is working in the Bone Metabolic Unit of the Endocrinology Division of the Istituto Auxologico Italiano, IRCCS, a private not-for-profit clinical care and research institution.

Dr Bianchi  has done clinical research in the field of bone and mineral metabolism, focusing on the epidemiology, physiopathology and therapy of skeletal demineralizing diseases, and on the new diagnostic techniques for the measurement of bone mass (photon absorptiometry and X-ray bone densitometry, quantitative bone hystomorphometry, radioimmunological dosage of calciotropic hormones).

She authored or co-authored more than 300 scientific publications, and presented scientific communications in most International Conferences and Meetings on bone and mineral metabolism.

Pierre Marie, Paris, France
Email: Pierre.Marie@larib.inserm.fr

Pierre Marie PhD
Dr. Pierre Marie earned his PhD degree at the University of Paris 7 and completed a research fellowship on metabolic bone diseases at the Shriners Hospital in Montreal, Canada, where he became Assistant Professor at Mc Gill University. He is now Director of Research at CNRS, and Head of the Group on Osteoblast Biology and Pathology at Inserm Unit 606 and University Paris Diderot at Lariboisiere Hospital, Paris, France.
The focus of his research activities was on the regulation of bone formation, with particular interest in cell and molecular biology of the osteoblast, the determination of mechanisms involved in metabolic, physical and genetic bone diseases, and the effects of strontium in bone.
He is a Board Director of ECTS, a member of IBMS, ASBMR and ESE. He serves as Editor of the European Journal of Endocrinology and in the Editorial Board for Bone and Calcified Tissue International. He served as a consultant for several organizations at the national and international levels, and for pharmaceutical companies. He has been an ad hoc reviewer for more than 20 journals. He has authored and co-authored over 190 articles and 100 reviews and chapters in books.

Adolfo Diez-Perez, Barcelona, Spain
Email: ADiez@imas.imim.es

Adolfo Diez-Perez MD
Head Department of Internal Medicine at the Hospital del Mar, Barcelona. Professor of Medicine at the Autonomous University of Barcelona. Associate Professor at the Johns Hopkins-Bloomberg University. Clinician involved in translational and epidemiological research in charge of a research unit at the Municipal Institute of Medical Research (IMIM) in Barcelona. 138 articles in peer-reviewed journals (both as Diez A or as Diez-Perez A). More than 250 abstracts in congresses. Former president of the Spanish Society of Bone and Mineral Research (2000-2002). Vice-president of  the Spanish Society of Osteoporotic Fractures (2007-). Member of the Committee of Scientific Advisors of the IOF (2007-). Member of the Board of Directors of the IBMS (2008-). Member of the committee of the WHO for reproductive health (1998-2002). Visiting scientist at Creighton University (Omaha, NE) (1992). Senior Medical Advisor for Eli Lilly (Indianapolis IN) (2002-2004). Reviewer for bone-focused and general journals. Reviewer for national and international official research agencies.

Socrates Papapoulos, Leiden, The Netherlands
Email: m.v.iken@lumc.nl

Socrates Papapoulos MD
Socrates Papapoulos is Professor of Medicine, Consultant Physician and Director of Bone and Mineral Research at the Department of Endocrinology and Metabolic Diseases of the Leiden University Medical Center, the Netherlands. He received his MD from the University of Athens, Greece and he was trained in Internal Medicine and Endocrinology in Athens and at the Middlesex Hospital, London, UK. Since 1974 he has been continuously engaged in basic and clinical research in disorders of calcium and bone metabolism with special emphasis on the basic and clinical pharmacology of the bisphosphonates particularly in osteoporosis. More recently a main focus of his research has been the pathophysiology of conditions characterized by high bone mass.

A former President of the Dutch Society for Calcium and Bone Metabolism, he has served on numerous boards and committees including the Board and the Scientific Advisory Board of the European Foundation of Osteoporosis and of the International Osteoporosis Foundation, the Board of Directors of the International Bone and Mineral Society, the European Union committee for the prevention of osteoporosis and a WHO task force for the development of a world wide strategy for the prevention and treatment of osteoporosis.

Dr Papapoulos is recipient of several awards and distinctions, he has served, among other, on the editorial boards of Bone and Mineral, Bone and Osteoporosis International and he has more than 300 publications.